We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Sonida Senior Living
SNDA
$1.88B
| $213K | ﹤0.01% |
934
+34
| +4% | +$7.35K |
|
|
BANX
1127
ArrowMark Financial
BANX
$194M
| $212K | ﹤0.01% |
10,370
| – | – |
|
1128
Cooper-Standard Automotive
CPS
$512M
| $211K | ﹤0.01% |
+2,084
| New | +$223K |
|
1129
Energizer
ENR
$1.38B
| $211K | ﹤0.01% |
+4,400
| New | +$239K |
|
1130
Pediatrix Medical
MD
$2.09B
| $210K | ﹤0.01% |
3,475
-118
| -3% | -$6.99K |
|
1131
NCR Voyix
VYX
$1.03B
| $210K | ﹤0.01% |
8,373
| – | – |
|
1132
XPO
XPO
$25.1B
| $210K | ﹤0.01% |
9,391
-8,131
| -46% | -$152K |
|
|
GOV
1133
DELISTED
Government Properties Income Trust
GOV
| $210K | ﹤0.01% |
11,480
-300
| -3% | -$6.53K |
|
|
SYT
1134
DELISTED
Syngenta Ag
SYT
| $210K | ﹤0.01% |
2,264
-2,093
| -48% | -$192K |
|
1135
Carter's
CRI
$1.37B
| $209K | ﹤0.01% |
+2,352
| New | +$207K |
|
1136
Aramark
ARMK
$15B
| $208K | ﹤0.01% |
7,040
-1,023
| -13% | -$28K |
|
1137
United Parks & Resorts
PRKS
$2.05B
| $208K | ﹤0.01% |
+12,779
| New | +$220K |
|
1138
First Trust Health Care AlphaDEX Fund
FXH
$1B
| $207K | ﹤0.01% |
+3,096
| New | +$199K |
|
1139
Domino's
DPZ
$10.5B
| $206K | ﹤0.01% |
+976
| New | +$193K |
|
1140
FMC
FMC
$1.45B
| $206K | ﹤0.01% |
3,254
-364
| -10% | -$23.4K |
|
|
CVGW
1141
DELISTED
Calavo Growers
CVGW
| $205K | ﹤0.01% |
+2,969
| New | +$200K |
|
1142
Highwoods Properties
HIW
$3.6B
| $205K | ﹤0.01% |
+4,050
| New | +$207K |
|
1143
Teradyne
TER
$58.2B
| $205K | ﹤0.01% |
6,841
+41
| +0.6% | +$1.38K |
|
1144
Cohen & Steers Infrastructure Fund
UTF
$3.1B
| $205K | ﹤0.01% |
+8,672
| New | +$198K |
|
1145
Darden Restaurants
DRI
$22.1B
| $203K | ﹤0.01% |
+2,240
| New | +$196K |
|
|
VTLE
1146
DELISTED
Vital Energy
VTLE
| $203K | ﹤0.01% |
964
+176
| +22% | +$43.4K |
|
1147
Ingredion
INGR
$6.36B
| $202K | ﹤0.01% |
1,698
| – | – |
|
1148
Molson Coors Class B
TAP
$7.45B
| $202K | ﹤0.01% |
2,335
-227
| -9% | -$21K |
|
|
CAJ
1149
DELISTED
Canon, Inc.
CAJ
| $202K | ﹤0.01% |
+5,916
| New | +$199K |
|
1150
State Street SPDR S&P Regional Banking ETF
KRE
$4.77B
| $201K | ﹤0.01% |
+3,648
| New | +$196K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.